Bristol Myers Squibb (BMY) agreement with Microsoft (MSFT), a market leader in AI-powered radiology and clinical workflow technologies, aiming to accelerate early detection of lung cancer

Bristol Myers Squibb's partnership with Microsoft appears to signal a significant strategic move into AI-powered technologies for early lung cancer detection.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Paypal (PYPL) introduces free DIY tax filings for debit card customers

Netflix (NFLX) and Warner Bros Discovery (WBD) announced they have amended their definitive agreement for Netflix’s pending acquisition of Warner Bros. to an all-cash transaction; valued at USD 27.75 per WBD share, unchanged from the prior

Bristol Myers Squibb (BMY) agreement with Microsoft (MSFT), a market leader in AI-powered radiology and clinical workflow technologies, aiming to accelerate early detection of lung cancer

50k TYH6 calls at a 112.5 strike were purchased for 16 ticks vs TYH6 at 111-15+, Bloomberg reports citing traders; a trade that targets the US 10yr yield moving below 4.13%, expiry 20th February

Fastenal Company (FAST) Q4 (USD): EPS 0.26 (exp. 0.26), Revenue 2.03bln (exp. 2.04bln); guides initial FY26 rev. double-digit growth, supported by FMI tech and digital solutions

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This collaboration highlights the increasing trend of tech companies integrating with healthcare to drive innovation, which could enhance BMY’s value proposition in the oncology space and potentially attract investor interest in both firms' future growth prospects.

Related headlines

The whole workspace, free to try.

Try it free